Vital Statistics of the United States. Rockville, MD, National Center for Health Statistics, 1975, Vol 2, part A, DHEW Pub No HRA 76–1102.
3.
LevyRIFeinleibM: Risk factors for coronary heart disease and their management, in BraunwaldE, (ed): Heart Disease. Philadelphia, WB Saunders, 1980, pp 1246–1278.
4.
KannelWBMcGeeDGordonT: A general cardiovascular risk profile: The Framingham Study. Am J Cardiol1976; 38:46.
5.
MosesC: Atherosclerosis: Mechanisms as a guide to prevention. Philadelphia, Lea and Febiger, 1963, pp 74–90.
6.
American Heart Association: Risk factors and coronary disease: A statement for physicians. Circulation1980; 62:445A.
7.
KannelWBGordonTSchwartzM: Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham Study. Am J Cardiol1971; 27:335–345.
8.
KeysA: Coronary heart disease in seven countries. Circulation1970; 41(Suppl I):I-1–I-211.
9.
GordonTCastelliWHjortlandM: High density lipoprotein as a protective factor against coronary artery disease: The Framingham Study. Am J Med 1977; 62:707.
10.
The Health Consequences of Smoking. Washington, DC, US Public Health Service, 1973.
11.
FeinleibMWilliamsR: Relative risks of myocardial infarction, cardiovascular disease and peripheral vascular disease by type of smoking. Proc Third World Conference: Smoking and Health1976; 1:243.
12.
GordonTKannelWMcGeeD: Death and coronary attacks in men after giving up cigarette smoking: The Framingham Study. Lancet1974; 2:1345.
Adult use of tobacco, 1975. Atlanta, Center for Disease Control, June 1976.
15.
KannelWMcGeeD: Diabetes and cardiovascular risk factors: The Framingham Study. Circulation1979; 59:1.
16.
GarciaMMcNamaraPGordonT: Morbidity and mortality of diabetes in the Framingham Population: Sixteen year follow-up study. Diabetes1976; 23:105.
17.
Coronary Drug Project Research Group: The prognostic importance of glucose levels and the use of hypoglycemic drugs after myocardial infarction in men. Diabetes1977; 26:453.
18.
University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes1970; 19(Suppl 2):785.
19.
GordonTCastelliWHjortlandM: Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women: The Framingham Study. Ann Intern Med1977; 87:393.
20.
FriedmanHRosenmanR: Type A behavior and your heart. New York, Alfred A Knopf, 1974.
21.
HaynesSFeinleibMKannelW: The relationship of psychosocial factors to coronary heart disease in the Framingham Study. Am J Epidemiol1980; 111:1.
22.
JenkinsCRosenmanRZyzanskiS: Prediction of clinical coronary heart disease by a test for the coronary-prone behavior pattern. N Engl J Med1974; 290:23.
23.
McGeeDGordonT: An epidemiological investigation of cardiovascular disease: The Framingham Study. US Dept. of HEW 76–1083, Section 31, 1976.
24.
Coronary Risk Handbook, Estimating risk of coronary heart disease in daily practice. New York. American Heart Association, 1973.